Skip to main content
. 2022 Jan 19;2022:9095504. doi: 10.1155/2022/9095504

Table 6.

Effect of G. procumbens on the activities of glycolytic enzymes in the kidney of control and experimental rats.

Group Hexokinase (n moles of glucose-6-phosphate formed/min/mg/protein) Aldolase (n moles of glyceraldehyde formed/min/mg protein) Phosphoglucoisomerase (n moles of fructose formed/min/mg protein)
C 291.64 ± 10.52 222.7 ± 13.64 31.64 ± 3.67
A 82.7 ± 5.05 286.26 ± 19.86 18.48 ± 2.90
A + M100 152.46 ± 6.88 263.86 ± 11.38 24.36 ± 2.31
A + M200 234.1 ± 7.3 243.06 ± 10.98 27.02 ± 2.99
A + M500 274.94 ± 9.61 229.54 ± 4.75 30.3 ± 1.77
A + G500 142.32 ± 10.59 267.5 ± 6.04 24.98 ± 2.08
A + G750 221.92 ± 7.69 241.94 ± 10.34 30.16 ± 2.26
A + G1000 260.28 ± 8.788 224.68 ± 7.75 28.68 ± 2.07
M100 292.56 ± 17.18 225.74 ± 9.55 28.4 ± 3.09
M200 290.56 ± 8.18 212.58 ± 2.27 29.62 ± 2.83
M500 288.36 ± 9.30 225.38 ± 7.98 30.7 ± 1.93
G 500 291.16 ± 6.76 219.34 ± 7.28 29.98 ± 1.23
G 750 288 ± 13.13 223.74 ± 8.75 32 ± 1.86
G 1000 279.6 ± 12.72 219.42 ± 8.52 32.8 ± 2.07

p < 0.05 indicates a significant difference from the disease group (C = control group, A = alloxan-treated group, M = metformin, A + M = alloxan + metformin, A + G = alloxan + Gynura, and G = G. procumbens).